NCT03109600 - Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I) | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

April 18, 2017

Primary Completion Date

September 28, 2017

Study Completion Date

February 19, 2018

Conditions

Safety Issues

Interventions

BIOLOGICAL

Vi-DT (Bio Farma)

Typhoid Conjugate Vaccine

BIOLOGICAL

Vi polysaccharide vaccine

BIOLOGICAL

Influenzae vaccine

1 dose of Influenzae vaccine

BIOLOGICAL

Pneumococcal conjugate vaccine

1 dose of Pneumococcal conjugate Vaccine

Trial Locations (2)

Puskesmas Jatinegara, Jakarta

Jatinegara Primary Health Center, Jakarta